Conversion therapy from N3 unresectable lung adenocarcinoma to radical surgery: a case report

Huali Hu; Shuai Zou; Ruofu Xu; Yoshinobu Ichiki; Dirk De Ruysscher; Fenglei Yu; Aihui Liao

doi:10.21037/atm.2019.09.113

Conversion therapy from N3 unresectable lung adenocarcinoma to radical surgery: a case report

Huali Hu, Shuai Zou, Ruofu Xu, Yoshinobu Ichiki, Dirk De Ruysscher, Fenglei Yu, Aihui Liao^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Article number	590
Number of pages	6
Journal	Annals of translational medicine
Volume	7
Issue number	20
DOIs	https://doi.org/10.21037/atm.2019.09.113
Publication status	Published - Oct 2019

Keywords

Conversion treatment
immunotherapy neoadjuvant treatment
N3 locally advanced NSCLC
CANCER

Access to Document

10.21037/atm.2019.09.113

Cite this

Hu, H., Zou, S., Xu, R., Ichiki, Y., De Ruysscher, D., Yu, F., & Liao, A. (2019). Conversion therapy from N3 unresectable lung adenocarcinoma to radical surgery: a case report. Annals of translational medicine, 7(20), [590]. https://doi.org/10.21037/atm.2019.09.113

@article{1bdcd510a95b446eb61fb170b1506328,

title = "Conversion therapy from N3 unresectable lung adenocarcinoma to radical surgery: a case report",

keywords = "Conversion treatment, immunotherapy neoadjuvant treatment, N3 locally advanced NSCLC, CANCER",

author = "Huali Hu and Shuai Zou and Ruofu Xu and Yoshinobu Ichiki and {De Ruysscher}, Dirk and Fenglei Yu and Aihui Liao",

year = "2019",

month = oct,

doi = "10.21037/atm.2019.09.113",

language = "English",

volume = "7",

journal = "Annals of translational medicine",

issn = "2305-5839",

publisher = "AME Publishing Company",

number = "20",

}

TY - JOUR

T1 - Conversion therapy from N3 unresectable lung adenocarcinoma to radical surgery

T2 - a case report

AU - Hu, Huali

AU - Zou, Shuai

AU - Xu, Ruofu

AU - Ichiki, Yoshinobu

AU - De Ruysscher, Dirk

AU - Yu, Fenglei

AU - Liao, Aihui

PY - 2019/10

Y1 - 2019/10

KW - Conversion treatment

KW - immunotherapy neoadjuvant treatment

KW - N3 locally advanced NSCLC

KW - CANCER

U2 - 10.21037/atm.2019.09.113

DO - 10.21037/atm.2019.09.113

M3 - Article

VL - 7

JO - Annals of translational medicine

JF - Annals of translational medicine

SN - 2305-5839

IS - 20

M1 - 590

ER -